Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
作者信息
Rantalaiho Vappu Marianna, Kautiainen Hannu, Korpela Markku, Hannonen Pekka J, Leirisalo-Repo Marjatta, Möttönen Timo
出版信息
Ann Rheum Dis. 2013 May;72(5):786-8. doi: 10.1136/annrheumdis-2012-202737. Epub 2013 Jan 24.
Abstract
摘要
相似文献
1
Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.将柳氮磺胺吡啶换用甲氨蝶呤并不能改善早期类风湿关节炎初始单一改善病情抗风湿药治疗的2年结局：芬兰类风湿关节炎联合改善病情抗风湿药治疗试验的亚组分析
Ann Rheum Dis. 2013 May;72(5):786-8. doi: 10.1136/annrheumdis-2012-202737. Epub 2013 Jan 24.
2
Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.根据早期类风湿关节炎中预测的与观察到的影像学进展情况，早期强化治疗可诱导出良好的影像学结果：随机FIN-RACo和NEO-RACo试验的亚组分析
Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1065-1071. Epub 2016 Aug 31.
3
Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.FIN-RACo 试验的长期结果；在早期类风湿关节炎中，联合使用传统的疾病修饰抗风湿药物治疗是一个极好的选择。
Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S27-31. Epub 2012 Oct 16.
4
Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.早期联合疾病修饰抗风湿药物治疗和严格疾病控制可改善早期类风湿关节炎患者的长期放射学结局：芬兰类风湿关节炎联合治疗试验的 11 年结果。
Arthritis Res Ther. 2010;12(3):R122. doi: 10.1186/ar3060. Epub 2010 Jun 24.
5
Remission as the treatment goal--the FIN-RACo trial.以缓解为治疗目标——芬兰类风湿关节炎控制试验
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-74-6.
6
[The goal for the treatment of rheumatoid arthritis should be remission].类风湿关节炎的治疗目标应为病情缓解。
Duodecim. 2010;126(12):1457-64.
7
Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.抗瓜氨酸化肽抗体与 FIN-RACo 联合治疗与单 DMARD 策略治疗早期类风湿关节炎患者放射学关节侵蚀进展的关系。
Clin Exp Rheumatol. 2011 May-Jun;29(3):500-5. Epub 2011 Jun 29.
8
The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.甲氨蝶呤、柳氮磺胺吡啶和羟氯喹联合使用对类风湿性关节炎疗效显著。
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):39-40.
9
Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.联合使用羟氯喹、柳氮磺胺吡啶和甲氨蝶呤的改善病情抗风湿药治疗。
Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S53-8.
10
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.早期类风湿关节炎联合治疗与单药治疗的比较：一项随机试验。芬兰类风湿关节炎联合治疗试验组
Lancet. 1999 May 8;353(9164):1568-73. doi: 10.1016/s0140-6736(98)08513-4.
Zotero 插件